HOPKINTON, Mass., Nov. 3, 2010 /PRNewswire-FirstCall/ —
Caliper Life Sciences, Inc. (Nasdaq:
CALP), a leading provider of tools and services for drug
discovery and life sciences research, today announced a
collaboration with Sony DADC Austria AG for the co-development and
manufacture of plastic consumables for Caliper’s next generation
microfluidics products. The agreement combines Sony DADC’s premier
Blu-ray Disc™ manufacturing technology and manufacturing
capacity with Caliper’s extensive microfluidics expertise and
patent portfolio to develop enabling solutions for life science
researchers and for diagnostic applications.
Caliper Life Sciences and Sony DADC have co-developed
consumables for the LabChip® XT system, Caliper’s automated
nucleic acid fractionation instrument for next generation
sequencing applications. The LabChip XT removes a key bottleneck in
sequencing workflows by replacing tedious gel isolation and
purification steps used in size selection. The plastic chips
manufactured by Sony DADC allow Caliper to offer a cost-effective
and disposable consumable that eliminates cross-contamination
potential, which is of key concern for genomics researchers.
“The exacting requirements for fragment size control in Next Gen
Sequencing are best addressed with Caliper’s patented microfluidics
technology, while the scale of the opportunity created an
opportunity for outsourced manufacturing and the transition to
plastic chip format,” said Kevin Hrusovsky, President and CEO of
Caliper Life Sciences. “We selected Sony DADC, the world’s largest
producer of super high quality Blu-ray discs, because of their
outstanding quality and large volume manufacturing
credentials.”
“Sony DADC is pleased to partner with Caliper Life Sciences to
co-develop breakthrough microfluidic technologies based on our high
volume plastic consumable manufacturing capabil
‘/>”/>
